Solace Revenue, Valuation, Funding & Investors

Solace is valued at $1B as of February 2026.

Last Solace valuation

$1B

Series C · Feb 2026

Last Solace funding round

$130M

Series C · Feb 2026

Solace revenue

$100M

Series B · Apr 2025

Key investors in Solace

  • RiverPark Ventures
  • Inspired Capital Partners
  • Torch Capital
  • Menlo Ventures
  • Craft Ventures
  • SignalFire

Solace Overview

About Solace

Solace is a nationwide healthcare advocacy service covered by Medicare that connects patients with physician and nurse advocates. Boston-headquartered, advocates handle insurance appeals, appointment scheduling, and care coordination via video, phone, text, or email. The service reports 98% improved outcomes for patients managing complex conditions like cancer and chronic illnesses across US healthcare systems.


Founded

2022

HQ

United StatesSan Francisco, CA

Status

Privately held

Customer focus

B2C

Revenue model

Services

Revenue

$100M (Apr 2025)

Valuation

$1B (Feb 2026)

Solace Valuation

Solace is currently valued at $1B, based on its Series C in February 2026.

The $130M round was led by IVP, with participation from Menlo Ventures, RiverPark Ventures, Torch Capital, SignalFire and Inspired Capital Partners.

Solace's valuation has moved from $1B at its Series B in April 2025 to $1B in February 2026, across 2 priced rounds.

Solace valuation by funding round

Revenue multiple
Solace valuation by funding round
DateStageValuationRevenue Multiple
Feb 2026Series C$1B-
Apr 2025Series B$1B10.0x

Solace Revenue

Solace's latest recorded revenue is $100M, as of its Series B in April 2025. At a $1B valuation, that implies a 10.0x revenue multiple.

Solace revenue by funding round

Solace revenue and valuation multiple by funding round
DateRevenue *ValuationRevenue MultipleStage
Apr 2025$100M$1B10.0xSeries B

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

Solace Funding History

Solace has raised a total of $204M across 3 funding rounds.

Solace's first fundraising round was a $14M Series A in August 2024. The most recent completed round was a $130M Series C in February 2026.

Solace funding rounds

Solace funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Feb 2026Series CIVP (lead); Menlo Ventures; RiverPark Ventures; Torch Capital; SignalFire; Inspired Capital Partners$130M$1BSolace Health is a health advocacy startup founded in 2022 by CEO Jeremy Gurewitz, motivated by his mother's experience with pancreatic cancer. The company operates a platform that connects patients with over 2,000 registered nurse advocates to navigate the U.S. healthcare system, including scheduling appointments, understanding treatment plans, interpreting medical bills, coordinating care, securing insurance approvals, and managing chronic conditions. Solace generates revenue by taking a variable share of Medicare reimbursements paid to advocates on its platform, and it features technology for Medicare billing and an in-house electronic medical records system. On February 10, 2026, Solace Health raised $130 million in a Series C funding round led by IVP, with participation from Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures. This round brought the company's post-money valuation to $1 billion, achieving unicorn status, and increased total funding to $211 million following a $60 million Series B in 2025 and $14 million Series A in 2024. The valuation is consistently reported across multiple sources as $1 billion or over $1 billion. The new capital will support expansion of the advocate network for Medicare and Medicare Advantage members, enhancements to the technology platform, marketing, hiring in engineering, product, and design, establishment of a research team for clinical and financial impact studies, and broader partnerships with payers and providers to embed advocacy earlier in patient journeys. Solace has served 200,000 patients and families, with 20,000 patients noted in one report, and is growing 10x year-over-year. In the competitive landscape, Solace differentiates with a human-centered approach amid AI advancements in healthcare, focusing on aging and longevity themes. Comparable players include Citizen Health, which raised $30 million in Series A for rare disease advocacy, totaling $44 million since 2023. IVP's investment aligns with scaling models like mental health platforms Grow Therapy and Headway that manage insurance reimbursements.
Apr 2025Series BMenlo Ventures (lead); RiverPark Ventures; Torch Capital; SignalFire; Craft Ventures; Inspired Capital Partners$60M$1BSolace Health is a health advocacy startup founded in 2022 by CEO Jeremy Gurewitz, motivated by his mother's experience with pancreatic cancer. The platform connects patients with over 2,000 registered nurse advocates to navigate the U.S. healthcare system, including scheduling appointments, understanding treatment plans, interpreting medical bills, coordinating care, securing insurance approvals, and managing chronic conditions. It features technology for Medicare billing, an in-house electronic medical records system, and generates revenue by taking a variable share of Medicare reimbursements paid to advocates. In February 2026, Solace Health raised $130 million in a Series C round led by IVP, with participation from Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures, achieving a post-money valuation exceeding $1 billion and unicorn status. This brought total funding to $211 million, following a $60 million Series B in 2025 and $14 million Series A in 2024. The capital will fund marketing, hiring in engineering, product, and design, expanding the advocate network for Medicare and Medicare Advantage members, enhancing the technology platform, supporting clinical research for medical journal publications, and pursuing payer and provider partnerships to embed advocacy earlier in patient journeys. IVP's Eric Liaw compared Solace's model to mental health platforms like Grow Therapy and Headway, which manage insurance reimbursements and administration. Medicare began covering advocacy services in 2024 for chronic and complex conditions, with ambitions for private insurer coverage. The company envisions a training academy to meet growing demand for advocates amid rising healthcare costs and system fragmentation. Competitors include Citizen Health, focused on rare diseases, with $44 million total funding.
Aug 2024Series AInspired Capital Partners (lead); RiverPark Ventures; Torch Capital; Susan Wojcicki; Anne Wojcicki; Coalition Operators; Craft Ventures$14M--

Who has invested in Solace?

10 investors have backed Solace across its funding rounds, including RiverPark Ventures, Inspired Capital Partners, Torch Capital, Menlo Ventures, Craft Ventures and SignalFire.

Lead investors include IVP, Menlo Ventures and Inspired Capital Partners.


Solace Investors

Investors in Solace by funding rounds participated
InvestorHQRoundsRoleFirst check
RiverPark VenturesUnited StatesNew York City, NY3ParticipantAug 2024
Torch CapitalUnited StatesNew York City, NY3ParticipantAug 2024
Inspired Capital PartnersUnited StatesNew York City, NY3LeadAug 2024
Menlo VenturesUnited StatesSan Francisco, CA2LeadApr 2025
SignalFireUnited StatesSan Francisco, CA2ParticipantApr 2025
Craft VenturesUnited StatesSan Francisco, CA2ParticipantAug 2024
IVPUnited StatesSan Francisco, CA1LeadFeb 2026
Susan WojcickiUnited StatesSan Francisco, CA1ParticipantAug 2024

This data is available for Pro users. Sign up to see all 10 Solace investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Solace Competitors

Solace competitors include listed companies like Teladoc and Talkspace, and private ones like DocPlanner, Forward, Huma and Miaoshou Doctor.

Public and private companies comparable to Solace
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
DocPlannerPolandWarsawPrivate--$1B-
ForwardUnited StatesSan Francisco, CAPrivate--$1B-
HumaUnited KingdomLondonPrivate--$1B-
Miaoshou DoctorChinaBeijingPrivate--$1B-
TeladocUnited StatesUnited StatesPublicly listed$2.5B$124M$1.1B0.6x
TalkspaceUnited StatesUnited StatesPublicly listed$229M$6M$871M3.4x

Solace Public Comps

Solace is still privately-owned, but its public comps include Talkspace, Teladoc, GoodRx, JMDC, Guiyang Longmaster, Medley Inc., Ping An Healthcare, American Well, Nyxoah and LifeMD.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Talkspace$229M$6M3.4x3.4x129.3x49.4x
Teladoc$2.5B$124M0.6x0.6x11.3x5.0x
GoodRx$797M$173M1.8x1.8x8.1x5.5x
JMDC$324M$88M5.0x4.6x18.4x17.9x
Guiyang Longmaster$44M$5M10.0x-87.9x-
Medley Inc.$236M$32M2.1x1.8x15.7x13.2x
Ping An Healthcare$815M$52M0.9x0.9x13.4x16.9x
American Well$249M($63M)0.2x0.2x(0.8x)(3.1x)

This data is available for Pro users. Sign up to see all Solace competitors and their valuation data.

Start Free Trial

Common questions about Solace

When was Solace founded?Solace was founded in 2022.
Where is Solace headquartered?Solace is headquartered in San Francisco, CA, United States.
Is Solace publicly listed?No, Solace is a private, VC-backed company.
What is Solace's valuation?Solace was last valued at $1B in its Series C in February 2026.
How much funding has Solace raised?Solace has raised $204M across 3 funding rounds.
What was Solace's last funding round?Solace's last funding round was a $130M Series C in February 2026, led by IVP.
Who are Solace's investors?Solace's investors include RiverPark Ventures, Torch Capital, Inspired Capital Partners, Menlo Ventures, SignalFire, Craft Ventures, IVP, Susan Wojcicki, Anne Wojcicki and Coalition Operators.
What is Solace's revenue?Solace's latest recorded revenue is $100M (April 2025).
What is Solace's revenue multiple?Solace's latest valuation implies a 10.0x revenue multiple ($1B valuation on $100M of revenue).
Which companies are comparable to Solace?Companies comparable to Solace include DocPlanner, Forward, Huma, Miaoshou Doctor, Teladoc and Talkspace.

See companies similar to Solace

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial